Chengyi Huang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
AURKA promotes radioresistance in pancreatic cancer via GSK3β-mediated PTEN phosphorylation at T366.
AURKA promotes radioresistance in pancreatic cancer via GSK3β-mediated PTEN phosphorylation at T366.
Journal: Experimental cell research
Published: November 20, 2025
Confinement-Locking Strategy Enables Ionogels With Remarkable Mechanical Robustness and Fatigue Resistance.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 13, 2025
Discovery of Novel Drug-Conjugate Molecule ZM484 with Dual p53-MDM2 and TOP1 Inhibition for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: September 04, 2025
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.
Journal: Cancer communications (London, England)
Published: April 24, 2025
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis.
Journal: Cancer cell international
Published: December 09, 2024
Rifaximin alleviates irinotecan-induced diarrhea in mice model.
Journal: Annals of medicine
Published: November 22, 2024
Mechanisms and emerging strategies for irinotecan-induced diarrhea.
Journal: European journal of pharmacology
Published: December 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026